Loading...
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
Around 80–90% of prostate cancer (PCa) cases are dependent on androgens at initial diagnosis; hence, androgen ablation therapy directed toward a reduction in serum androgens and the inhibition of androgen receptor (AR) is generally the first therapy adopted. However, the patient’s response to androg...
Na minha lista:
| Udgivet i: | Cells |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7763510/ https://ncbi.nlm.nih.gov/pubmed/33321757 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9122653 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|